Outset Medical Inc (OM) Stock Forecast & Price Target
Outset Medical Inc · NASDAQ
$4.30+0.27 (+6.56%)
15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering Outset Medical Inc, 2 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets range widely, $8.00 to $17.00 (about 2.1x), a sign of real disagreement on valuation. The average target of $13.33 sits 210% above the current $4.30. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.65 next quarter toward $-2.18 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Moderate Buy
Strong Buy00%
Buy267%
Hold133%
Sell00%
Strong Sell00%
Based on 3 analysts giving stock ratings to Outset Medical Inc.
As of Jul, 2 of 3 firms rate OM a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
OM EPS & revenue forecast
EPS · NEXT QUARTER
$-0.65
Range $-0.67 – $-0.63 · 3 analysts · -6% YoY
Next period, 3 analysts expect Outset Medical Inc to earn $-0.65 a share (range $-0.67 – $-0.63), versus $-0.69 a year earlier. Full-year consensus is $-2.91, growing to $-2.18 the year after.
REVENUE · NEXT QUARTER
$33.5M
Range $32.6M – $34.9M · 3 analysts · +14% YoY
Revenue is expected to reach $33.5M (range $32.6M – $34.9M), +13.9% year-over-year. Full-year consensus is $125.7M, rising to $139.3M next year.
Top analysts covering Outset Medical Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on OM.
#1
SS
Shagun Singh
RBC Capital
Hold
$17.00+294.9% to target
Coverage
—
+ Follow
#2
MT
Marie Thibault
BTIG
Buy
$15.00+248.4% to target
Coverage
—
+ Follow
#3
Rick Wise
Stifel
Buy
$8.00+85.8% to target
Coverage
—
+ Follow
#4
Suraj Kalia
Oppenheimer
Hold
No targeton OM
Coverage
—
+ Follow
#5
JJ
Joshua Jennings
TD Cowen
Buy
$3.00-30.3% to target
Coverage
—
+ Follow
OM stock forecast FAQ
What is OM's average 12-month price target?+
The 3 analysts with a live target average $13.33 for Outset Medical Inc over the next 12 months, ranging from a $17.00 high to a $8.00 low.
Is OM stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 3 analyst ratings, 2 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for OM?+
The Street-high target is $17.00 (RBC Capital), and the Street-low is $8.00 (Stifel). The average of all 3 active targets is $13.33.
How many Wall Street analysts cover OM?+
3 analysts have an active rating on Outset Medical Inc, and 3 firms carry a live 12-month price target.
Who is the most accurate analyst covering OM?+
Among analysts who currently cover OM, Shagun Singh of RBC Capital has the strongest overall Quantellect track record. Their current call is Hold with a $17.00 target.
What is Outset Medical Inc's projected EPS for next quarter?+
The consensus estimate is $-0.65 per share (range $-0.67 – $-0.63) across 3 analysts. Full-year EPS is projected at $-2.91, rising to $-2.18 the following year.
How much revenue is Outset Medical Inc expected to report next quarter?+
Consensus revenue is $33.5M (range $32.6M – $34.9M). Full-year revenue is projected at $125.7M, growing to $139.3M next year.
Have analysts been upgrading or downgrading OM lately?+
As of Jul, 2 of 3 firms rate OM a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their OM calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
